PT  - JOURNAL ARTICLE
AU  - Klein, Eran
AU  - Bourdette, Dennis
TI  - Postmarketing adverse drug reactions
AID  - 10.1212/CPJ.0b013e3182a1b9f0
DP  - 2013 Aug 01
TA  - Neurology: Clinical Practice
PG  - 288--294
VI  - 3
IP  - 4
4099  - http://cp.neurology.org/content/3/4/288.short
4100  - http://cp.neurology.org/content/3/4/288.full
AB  - Physicians play an important role in recognizing and reporting suspected adverse drug reactions (ADRs) to the Food and Drug Administration (FDA). Physicians can report suspected ADRs directly to the FDA via its MedWatch program, by contacting the manufacturer of the drug, and by publishing case reports. While this takes time, physicians have an ethical obligation to participate in recognizing and reporting ADR.